Health
AD-Smart: Alzheimer’s trial will test diabetes and ADHD drugs on patients
Key Points
A new clinical trial has been launched in the UK that researchers hope will cut years from the search for treatments for Alzheimer’s disease. The study will test multiple drugs simultaneously, starting with two repurposed medicines already used to treat type 2 diabetes and attention deficit/hyperactivity disorder (ADHD).It will examine whether the medicines can lessen symptoms such as memory and thinking problems and help people maintain their quality of life. Alzheimer’s is the most common...
A new clinical trial has been launched in the UK that researchers hope will cut years from the search for treatments for Alzheimer’s disease.The study will test multiple drugs simultaneously, starting with two repurposed medicines already used to treat type 2 diabetes and attention deficit/hyperactivity disorder (ADHD).It will examine whether the medicines can lessen symptoms such as memory and thinking problems and help people maintain their quality of life.Alzheimer’s is the most common type of dementia, affecting around 600 000 people in the UK. Data published today show that the NHS in England met its target to diagnose dementia in at least 66.7% of the patients over 65 who are estimated to have dementia for the first time since March 2020.1No current NHS treatments can slow or stop Alzheimer’s, although medicines can be used to manage its symptoms.2 The AD-Smart trial (Alzheimer’s disease Systematic Multi-arm Adaptive Randomised Trial) aims to...